ARA-290 (Cibinetide) vs Ipamorelin
ARA-290 (Cibinetide): Investigational 11-amino-acid peptide derived from the helix-B region of erythropoietin that activates the innate repair receptor without stimulating red-blood-cell production; studied for small-fiber neuropathy.
Ipamorelin: Gentle GH releaser that amps muscle growth and fat loss without the harsh sides.
ARA-290 (Cibinetide)
RecoveryInvestigational 11-amino-acid peptide derived from the helix-B region of erythropoietin that activates the innate repair receptor without stimulating red-blood-cell production; studied for small-fiber neuropathy.
Top benefits
- Activates the innate repair receptor to promote tissue protection and healing
- Reduced neuropathic pain symptoms in sarcoidosis small-fiber neuropathy trials
- Increased corneal nerve fiber measures (a marker of small-nerve regeneration) without raising hematocrit
Ipamorelin
PerformanceGentle GH releaser that amps muscle growth and fat loss without the harsh sides.
Top benefits
- Increases lean muscle mass
- Accelerates fat loss
- Improves sleep quality
- Enhances recovery
| Attribute | ARA-290 (Cibinetide) | Ipamorelin |
|---|---|---|
| Category | Recovery | Performance |
| Type | linear | linear |
| Chain length | 11 aa | 5 aa |
| Formula | helix-B 11-mer (non-erythropoietic EPO derivative) | C38H49N9O5 |
| Common dose | 2 mg IV or 1-8 mg SC | 200-300 mcg |
| Frequency | Three times weekly to daily (per trial) | Daily (Night) |
| Top benefit | Activates the innate repair receptor to promote tissue protection and healing | Increases lean muscle mass |
| Top side-effect | Generally well tolerated in trials | Flushing |
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.